Azacitidine With Nivolumab Improved Overall Survival in AML Patients
Publication year - 2018
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000550425.24055.64
Subject(s) - nivolumab , azacitidine , medicine , oncology , intensive care medicine , immunotherapy , biology , cancer , genetics , gene expression , dna methylation , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom